BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18558304)

  • 81. Deal watch: Amgen builds secondary hyperparathyroidism [corrected] pipeline.
    Tse MT
    Nat Rev Drug Discov; 2012 Jun; 11(6):430. PubMed ID: 22653204
    [No Abstract]   [Full Text] [Related]  

  • 82. Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
    Coyne DW
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):364-5. PubMed ID: 18477990
    [No Abstract]   [Full Text] [Related]  

  • 83. [Programmed approach to the treatment of secondary hyperparathyroidism in chronic renal disease].
    Samokhvalov NA; Maĭstrenko NA; Romashchenko PN
    Vestn Khir Im I I Grek; 2013; 172(2):43-6. PubMed ID: 24000678
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cinacalcet, fetuin-A and interleukin-6.
    Marino A; Giotta N
    Nephrol Dial Transplant; 2008 Apr; 23(4):1460-1; author reply 1461-2. PubMed ID: 18065786
    [No Abstract]   [Full Text] [Related]  

  • 85. [Treatment of secondary hyperparathyroidism in dialysis: Report of a case-study of treatment failure].
    Pruijm MT; Teta D; Wuerzner G; Santschi V; Burnier M
    Nephrol Ther; 2008 Feb; 4(1):28-33. PubMed ID: 18088578
    [TBL] [Abstract][Full Text] [Related]  

  • 86. No effect of renal function or dialysis on pharmacokinetics of cinacalcet (Sensipar/Mimpara).
    Padhi D; Harris RZ; Salfi M; Sullivan JT
    Clin Pharmacokinet; 2005; 44(5):509-16. PubMed ID: 15871636
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bimaxillary full arch fixed dental implant supported treatment for a patient with renal failure and secondary hyperparathyroidism and osteodystrophy.
    Flanagan D; Mancini M
    J Oral Implantol; 2015 Apr; 41(2):e36-43. PubMed ID: 24372491
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic.
    Seikrit C; Mühlfeld A; Groene HJ; Floege J
    Nat Rev Nephrol; 2011 Apr; 7(4):237-41. PubMed ID: 21151209
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Treatment with calcimimetics in kidney transplantation.
    Morales E; Gutierrez E; Andres A
    Transplant Rev (Orlando); 2010 Apr; 24(2):79-88. PubMed ID: 20303456
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Chronic kidney disease].
    Anders HJ
    Med Klin (Munich); 2005 Nov; 100(11):714-21. PubMed ID: 16328179
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia.
    Boulanger H; Haymann JP; Fouqueray B; Mansouri R; Metivier F; Sarfati E; Glotz D
    Nephrol Dial Transplant; 2005 Dec; 20(12):2865. PubMed ID: 16115841
    [No Abstract]   [Full Text] [Related]  

  • 92. Secondary hyperparathyroidism in human kidney transplant recipients.
    Pletka PG; Strom TB; Hampers CL; Griffiths H; Wilson RE; Bernstein DS; Sherwood LM; Merrill JP
    Nephron; 1976; 17(5):371-81. PubMed ID: 787818
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Persistent severe hypercalcemia during maintenance hemodialysis.
    Johnson WJ
    Ann Intern Med; 1980 Aug; 93(2):272-5. PubMed ID: 7406379
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient.
    Peng LW; Logan JL; James SH; Scott KM; Lien YH
    Am J Med; 2007 Sep; 120(9):e7-9. PubMed ID: 17765036
    [No Abstract]   [Full Text] [Related]  

  • 95. The DOPPS Practice Monitor for US Dialysis Care: PTH Levels and Management of Mineral and Bone Disorder in US Hemodialysis Patients.
    Tentori F; Zepel L; Fuller DS; Wang M; Bieber BA; Robinson BM; Pisoni RL
    Am J Kidney Dis; 2015 Sep; 66(3):536-9. PubMed ID: 26300197
    [No Abstract]   [Full Text] [Related]  

  • 96. Spontaneous remission of severe hyperparathyroidism in chronic renal failure.
    Charhon S; Sellem C; Meunier PJ; Traeger J
    Nephron; 1983; 33(1):53-5. PubMed ID: 6835455
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cinacalcet, paricalcitol, or both?
    Cozzolino M; Galassi A; Brancaccio D
    Nephrol Dial Transplant; 2007 Oct; 22(10):3087; author reply 3087-8. PubMed ID: 17623718
    [No Abstract]   [Full Text] [Related]  

  • 98. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Tripepi G
    N Engl J Med; 2013 May; 368(19):1843-4. PubMed ID: 23656657
    [No Abstract]   [Full Text] [Related]  

  • 99. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Goldsmith DJ; Lamb EJ
    N Engl J Med; 2013 May; 368(19):1843. PubMed ID: 23656656
    [No Abstract]   [Full Text] [Related]  

  • 100. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Locatelli F; Pontoriero G; Tentori F
    N Engl J Med; 2013 May; 368(19):1843. PubMed ID: 23656655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.